Finerenone Improves Cardiovascular, Kidney, and CKM Outcomes among diabetics with CKD: JAMA Written By Medha Baranwal25 Jun 2026 9:15 PM ISTUSA: Among patients with type 2 diabetes and chronic kidney disease, finerenone reduced the risk of cardiovascular and kidney events across all stages...
Finerenone Shows Potential to Preserve Kidney Function in Glomerular Diseases: FIND-CKD trial analysis Written By Medha Baranwal25 Jun 2026 8:30 PM ISTAustralia: An exploratory analysis has found that finerenone slowed the decline in kidney function, reduced albuminuria, and lowered the risk of...
Empagliflozin and finerenone Combo Provides Greater BP and Albuminuria Reduction: Study Written By Jacinthlyn Sylvia14 Jun 2026 10:15 PM ISTA new study published in the journal of Hypertension showed that participants with systolic blood pressure (SBP) >=130 mm Hg responded better to...
Finerenone Slows Kidney Function Decline and Lowers Cardio-Renal Risk in Non-Diabetic CKD: Major Trial Written By Dr. Kamal Kant Kohli12 Jun 2026 8:15 PM ISTFinerenone significantly slowed kidney function decline and reduced the risk of cardiovascular-kidney outcomes in adults with non-diabetic chronic...
Finerenone lowers CV and kidney risks in Type 2 diabetes with CKD: Study Written By Dr Kartikeya Kohli11 May 2026 10:00 AM ISTA study published in Diabetes, Obesity and Metabolism hasfound that finerenone reduced cardiovascular and kidney risks in patients with type 2...
EMPEROR-Preserved Score Predicts Outcomes and Identifies Greater Absolute Benefit with Finerenone Written By Dr Riya Dave6 April 2026 8:15 AM ISTIn the FINEARTS-HF Trial, the EMPEROR-Preserved Trial risk score showed broad applicability across outcomes. While baseline risk did not alter the...
Finerenone Slows Kidney Function Decline in Non-Diabetic CKD: Phase III FIND-CKD study Written By Dr. Kamal Kant Kohli19 March 2026 9:00 PM ISTThe Phase III FIND-CKD trial demonstrated that finerenone (Kerendia), when added to standard care, significantly reduced the rate of kidney function...
Finerenone Significantly Reduces Albuminuria in Type 1 Diabetes CKD, suggests study Written By Dr Riya Dave9 March 2026 11:00 AM ISTFinerenone has been shown to reduce urinary albumin excretion in adults with type 1 diabetes and chronic kidney disease (CKD) in a randomized clinical...
Bayer Finerenone approved in Japan for chronic heart failure Written By Ruchika Sharma22 Dec 2025 10:30 AM ISTBerlin: Bayer has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for finerenone (Kerendia), a non-steroidal, selective...
Finerenone Benefits Consistent Across Diuretic Subgroups in HFmrEF/HFpEF: JAMA Written By Jacinthlyn Sylvia20 Aug 2025 9:15 AM ISTA new study published in the Journal of American Medical Association showed that although it did not decrease the incidence of new loop diuretic...
FDA Expands Finerenone Indication to Include Heart Failure Prem Aggarwal16 July 2025 8:30 AM ISTThe FDA has broadened the approved use of finerenone (Kerendia) to include treatment for heart failure, according to an announcement by manufacturer...
Bayer gets USFDA nod for Finerenone for new indication in heart failure patients Written By Ruchika Sharma15 July 2025 11:35 AM ISTBerlin: Bayer has received approval from the U.S. Food and Drug Administration (FDA) for finerenone (Kerendia), a non-steroidal, selective...
